Clinical Endocrinology NewsMASLD linked to increased risk for various clinical outcomesOctober 9, 2023Lipid DisordersDiabetes
Clinical Endocrinology NewsLDL cholesterol lowering tied to less risk of first CVD events in patients older than 70September 27, 2023Lipid Disorders
Clinical Endocrinology NewsMuvalaplin and olpasiran show early promise in lowering Lp(a)September 19, 2023Lipid Disorders
Clinical Endocrinology NewsAHA reviews impact of aggressive LDL lowering on the brainSeptember 19, 2023Lipid Disorders
Clinical Endocrinology NewsFish oil labels make health claims, despite lack of dataSeptember 18, 2023HypertensionLipid Disorders
Clinical Endocrinology NewsTriglyceride puzzle: Do TG metabolites better predict risk?August 24, 2023Lipid Disorders
Clinical Endocrinology News‘Water fasting’ benefits don’t lastAugust 15, 2023ObesityDiabetesHypertensionLipid Disorders
Clinical Endocrinology NewsLow-dose colchicine for ASCVD: Your questions answeredAugust 11, 2023Lipid Disorders
Clinical Endocrinology NewsPrioritize nutrients, limit ultraprocessed food in diabetesAugust 9, 2023DiabetesLipid Disorders
Clinical Endocrinology NewsExercise program boosted physical, but not mental, health in young children with overweightJuly 28, 2023ObesityLipid DisordersPediatrics
Clinical Endocrinology NewsUSPSTF maintains ‘insufficient evidence’ for lipid disorder screenings in kids and teensJuly 18, 2023Lipid DisordersPediatrics
Clinical Endocrinology NewsFDA expands inclisiran statin-adjunct indication to include primary preventionJuly 11, 2023Lipid Disorders
Clinical Endocrinology NewsSAFE algorithm detects liver disease in general populationJune 26, 2023DiabetesLipid Disorders
Clinical Endocrinology News‘Striking’ benefit of lipid lowering in primary preventionJune 26, 2023Lipid DisordersDiabetes
Clinical Endocrinology News‘Exciting time for NASH’ with resmetirom phase 3 resultsJune 23, 2023Lipid Disorders
